Stay updated on Ipilimumab + Lymphodepletion + ACT + HD IL-2 Melanoma Mets Clinical Trial

Sign up to get notified when there's something new on the Ipilimumab + Lymphodepletion + ACT + HD IL-2 Melanoma Mets Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ipilimumab + Lymphodepletion + ACT + HD IL-2 Melanoma Mets Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The page revision was updated from v3.6.4 to v3.6.5, indicating a minor platform update with no changes to study content or visible information.
    Difference
    0.1%
    Check dated 2026-08-09T09:20:54.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    Revision updated from v3.6.3 to v3.6.4, indicating a minor maintenance update to the page. This change does not modify study data, eligibility criteria, or results.
    Difference
    0.1%
    Check dated 2026-07-25T18:03:43.000Z thumbnail image
  4. Check
    22 days ago
    No Change Detected
  5. Check
    36 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.2 to v3.6.3, signaling a page refresh. This appears to be a metadata-level update rather than a change to the study details.
    Difference
    0.1%
    Check dated 2026-07-04T13:13:57.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    The page now displays an updated revision label from v3.6.0 to v3.6.2, indicating a newer build of the page without changes to visible content or features.
    Difference
    0.1%
    Check dated 2026-06-27T07:46:29.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    The page now shows recruitment status as 'No longer looking for participants', indicating enrollment for this study has ended. New help and navigation sections—How to Read a Study Record, Common Questions, and How to Join a Study—were added, and the Interventions/Treatment header was updated; a revision note (Revision: v3.6.0) is also included.
    Difference
    0.4%
    Check dated 2026-06-13T05:09:05.000Z thumbnail image
  8. Check
    65 days ago
    Change Detected
    Summary
    The page footer now includes Moffitt branding and related trial links. The revision label changed from v3.5.4 to v3.5.5.
    Difference
    0.3%
    Check dated 2026-06-05T23:55:54.000Z thumbnail image

Stay in the know with updates to Ipilimumab + Lymphodepletion + ACT + HD IL-2 Melanoma Mets Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ipilimumab + Lymphodepletion + ACT + HD IL-2 Melanoma Mets Clinical Trial page.